Wall Street’s Evan David Seigerman stirred the pot by slashing his price target on Eli Lilly stock—but not his enthusiasm.

Natixis has significantly reduced its investment in Bank of America, trimming its stake by nearly 23% in the fourth quarter.

Procter & Gamble saw a significant shakeup in shareholder activity, especially as Ossiam slashed its holdings by more than ...

Tesla teased investors with a promise of a new low-cost model by mid-2025, sparking initial excitement—until details emerged.

Trajan Wealth LLC bulked up its Chevron stake by 7.6%, adding 2,372 shares and pushing its total to a 33,567-share pool worth ...

AbbVie is set to report earnings on April 25, with revenue expected to top $13.17 billion and EPS hitting $2.44. Insiders at ...

First Trust Advisors LP beefed up its stake in Home Depot by snagging nearly 32,000 more shares, now owning 680,703 in total.

Representative Robert Bresnahan, Jr. of Pennsylvania recently ditched some Meta Platforms shares, selling between $1,001 and ...

Tower Research Capital gave Johnson & Johnson’s portfolio a serious vitamin boost, increasing its stake by 71.4% in Q4. The ...

Ossiam offloaded nearly half of its JPMorgan Chase holdings in Q4, selling 33,181 shares and trimming its position to 33,666 ...

Berkshire Hathaway B is gaining investor attention, despite a recent dip in its stock performance. Over the past month, ...

Merck is set to release its Q1 2025 earnings before markets open Thursday, with analysts eyeing $2.16 EPS on $15.59B revenue.